1-0325-cover

March 2025

DDN%20Magazine%20May%202024.pdf

front-cover-may-2024

May 2024

A woman wearing a blue and purple shirt sits in front of a white wall with decorative mirrors.

arjumand-ghazi

Portrait of a woman wearing glasses, a purple sweater, and a multicolored scarf.

duncan-headshot

A researcher using a pipette to transfer a substance into a test tube.

garrison-headshot

A close-up of a scientist’s hands in black gloves holding an obscured object under a microscope.

untitled-design-2024-04-23t152711-353-1

A portrait of a woman with blonde hair in a black blazer.

img-5258

Slowing female reproductive aging could be the key to improving women&rsquo;s health.

Reproductive aging leads to many women&rsquo;s health problems

An illustrated image of an older woman looking at a younger version of herself with a clock behind them, representing reversing immune system aging

68492-ddn-custom-image-aging-1800-x-900-4-1

After decades of combating daily assaults, the immune system undergoes dramatic changes that drastically affect human health.

Explained: At what age does the immune system weaken?

Five cartoon vials of blood with a doctor holding a magnifying glass to one 

68491-1800x900-02-1

A man in a brown suit and purple button-down shirt

wyss-coray-lab-1

rando-photo-upgrade

untitled-design-2024-05-15t110013-261-1

A man in a suit holding an hourglass in front of a grandfather clock.

rubin-lee-copyright-harvard-2017-credit-kris-snibbe-harvard-university-original

A group of people standing on steps outside smiling

betterhumans-patient

A woman sitting in a chair getting a plasma infusion

Young blood rejuvenates aging organs in rodents. Researchers are studying the potential to use young blood-based treatments in aging humans too.

Young blood reverses aging in old organs

Aging

A headshot of Paolo Martini wearing a white shirt and dark blue suit jacket.

61878-1800-x-900

A 3D rendering of a yellow lipid nanoparticle holding an mRNA therapeutic is shown entering a pink human cell.

61878-1800-x-900-2

Paolo Martini leads the biotech company&rsquo;s rare disease research program with the hope of developing the very first treatments for genetic metabolic disorders.

Moderna&rsquo;s path to mRNA therapies for rare metabolic disorders

paul-nioi-2

A man smiles while wearing a blue suit jacket and red tie

kirk-brown4

A man smiles while wearing a pink button-down shirt and black vest

aiming-yu-lcms-2024

A microscopic view of white, orange, and green molecules

untitled-design-2024-05-17t113826-146-1

A man in a white coat sitting at a computer

phillip-sharp-22-09-26-mit-koch-institute-steve-boxall-3021-color-portrait

Alnylam Pharmaceuticals develops therapeutics based on the RNA interference (RNAi) pathway discovered in 1998.

Silencing genes to prevent disease with RNAi drugs

Two profile outlines of humans with scientific and artistic images overlaid.

istock-1474523316-1800x900

Two profile outlines of humans with scientific and artistic images overlaid

The pursuit of scientific knowledge relies on analytical thinking, but creativity also plays an essential role.

Science needs creativity

Editors Insight

A man in a black suit and blue button-down shirt.

johns-doug

spring-4

Two men in blue lab coats look at a clear bottle.

A group of people standing in a lab smiling with clear glasses on.

spring-3

White bowls with brown circular objects on a brown wooden background

68345-ddn-custom-article-image-goldilocks-1800-x-900-resized-1

david-baker-and-gaurav-bhardwaj-in-lab

By making peptides ring shaped, researchers uncovered a new class of drugs that is &ldquo;just right&rdquo; for previously undruggable targets.

A new Goldilocks drug class: macrocyclic peptides

Editor's Focus

Two Antion Biosciences researchers look at a fluorescent image on a computer monitor while wearing white lab coats and purple gloves.

untitled-design-2024-05-08t145137-608-1

A headshot of Marco Alessandrini wearing a dark jacket in front of a white background.

220913-antion-people-marco-2

A researcher wearing a white lab coat and purple gloves pipets liquid into a tube.

220913-antion-labo-127

A new approach to cell engineering could make off-the-shelf CAR T cell therapies a reality.

Silencing cancer with CAR T cells

The Multiply Labs team stands in and around their robotic modules.

fred

Inside the robotic cluster at Multiply Labs

robotic-cluster-inside-1

Fred Parietti stands with his arms folded in front of the Multiply Labs robots.

team

A photo of Multiply Labs’ modules, which stack on top of each other as well as side by side.

robotic-cluster-outside-2

Scientists and engineers teamed up to use robots to streamline cell therapy manufacturing, aiming to give more patients access to these lifesaving therapies.

The robots making cell therapies

Cell Therapy

A scientist at Entact Bio works in the laboratory.

untitled-design-2024-06-05t100349-506-1

The ubiquitin protein is shown in purple.

img1-2

A photo of Victoria Richon standing in a laboratory.

img2

Many diseases cause proteins to go haywire. Scientists are now developing drug molecules to change that.

Targeting disease proteins with molecular matchmakers

Protein Drugs

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.  

untitled-design-2025-03-12t163253-386

cn-bio-logo-colour-300mm

CN Bio

Discover how researchers leverage microphysiological systems in toxicology studies. &nbsp;

Harnessing liver-on-a-chip models for drug safety

Webinars

A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

78041-1800x900-2

Thermo Fisher Scientific

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.

Enhancing bioanalytical studies with centralized data management

Whitepaper

A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

untitled-design-2025-03-11t120646-259

takara-bio-inc-logo-vector

Takara Bio

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.

May 2024 Volume 20, Issue 3